Product Overview
MOTS-c: Metabolic Vitality & Exercise-Like Benefits
Why MOTS-c is of special interest to patients: Age-related metabolic slowdown, reduced exercise capacity, or insulin resistance can sap energy and vitality. MOTS-c acts like an “exercise mimetic,” supporting healthier metabolism and physical performance from the cellular level.
Potential Benefits Shown in Early Limited Evaluations Early studies (mostly pre-clinical and small human) suggest:
- Enhanced glucose tolerance and insulin sensitivity in metabolic models.
- Improved physical endurance and reduced age-related decline in exercise capacity.
- Support for metabolic flexibility and reduced inflammation. These are promising early findings; larger human trials are needed.
- Noted: MOTS-c has be stated to be stacked with other peptides. Possibly these stacks may provide for potential enhanced results depending on research indication of interest. These finding are limited and should be researched more fully in human studies for safety and efficacy. Human clinical data remains limited, and it is not FDA-approved for therapeutic use primarily researched or used off-label/investigationally.
MOTS-c is a 16-amino-acid peptide with the sequence MRWQEMGYIFYPRKLR.
It is a natural mitochondrial-derived peptide (metabolite) produced by the body’s own mitochondria to help regulate energy balance and stress adaptation.
How it works (Mechanism of Action): MOTS-c activates AMPK, influences the folate-AICAR pathway, and can translocate to the nucleus to turn on protective genes—improving insulin sensitivity, fat metabolism, and cellular resilience.
Backed by science:
- Pre-clinical studies in mice showed MOTS-c prevents diet-induced obesity, improves insulin sensitivity, and enhances exercise performance across age groups.
- Clinical data from an analog (CB4211) in early human trials confirmed safety and modest improvements in liver fat and metabolic markers in obese individuals.